Stephen Ubl, PhRMA president and CEO (Adrien Villez for Endpoints News)
December 14, 2023 03:23 PM EST
Pharma

PhRMA and BIO say Biden’s march-in pro­pos­al cre­ates un­cer­tain­ty in in­dus­try

Nicole DeFeudis

Editor

PhRMA pres­i­dent Stephen Ubl ar­gued Thurs­day that the Biden ad­min­is­tra­tion’s new pro­pos­al on the use of march-in rights has “plant­ed the seeds of un­cer­tain­ty” around …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times